Back to Search Start Over

Congenital diabetes mellitus

Authors :
Fabrizio Barbetti
Alessia Piscopo
Francesca Casaburo
Angela Zanfardino
Riccardo Bonfanti
Ivana Rabbone
Dario Iafusco
Emanuele Miraglia del Giudice
Maria Francesca Gicchino
Gulsum Ozen
Nadia Tinto
Fernanda Iafusco
Serena Meola
Iafusco, D.
Zanfardino, A.
Bonfanti, R.
Rabbone, I.
Tinto, N.
Iafusco, F.
Meola, S.
Gicchino, M. F.
Ozen, G.
Casaburo, F.
Piscopo, A.
Miraglia Del Giudice, E.
Barbetti, F.
Iafusco, Dario
Zanfardino, Angela
Bonfanti, Riccardo
Rabbone, Ivana
Tinto, Nadia
Iafusco, Fernanda
Meola, Serena
Gicchino, Maria Francesca
Ozen, Gulsum
Casaburo, Francesca
Piscopo, Alessia
Miraglia Del Giudice, Emanuele
Barbetti, Fabrizio
Publication Year :
2020
Publisher :
Edizioni Minerva Medica, 2020.

Abstract

Congenital diabetes mellitus is a rare disorder characterized by hyperglycemia that occurs shortly after birth. We define "Diabetes of Infancy" if hyperglycemia onset before 6 months of life. From the clinical point of view, we distinguish two main types of diabetes of infancy: transient (TNDM), which remits spontaneously, and permanent (PNDM), which requires lifelong treatment. TNDM may relapse later in life. About 50% of cases are transient (TNDM) and 50% permanent. Clinical manifestations include severe intrauterine growth retardation, hyperglycemia and dehydration. A wide range of different associated clinical signs including facial dysmorphism, deafness and neurological, cardiac, kidney or urinary tract anomalies are reported. Developmental delay and learning difficulties may also be observed. In this paper we review all the causes of congenital diabetes and all genes and syndromes involved in this pathology. The discovery of the pathogenesis of most forms of congenital diabetes has made it possible to adapt the therapy to the diagnosis and in the forms of alteration of the potassium channels of the pancreatic Beta cells the switch from insulin to glibenclamide per os has greatly improved the quality of life. Congenital diabetes, although it is a very rare form, has been at the must of research in recent years especially for pathogenesis and pharmacogenetics. The most striking difference compared to the more frequent autoimmune diabetes in children (type 1 diabetes) is the possibility of treatment with hypoglycemic agents and the apparent lower frequency of chronic complications.

Details

Language :
English
Database :
OpenAIRE
Accession number :
edsair.doi.dedup.....756e5a89fd318fa305c191bba1ffa423